Prostate Cancer - Results from #24920

Functional imaging for prostate cancer: Therapeutic implications - Abstract August 29, 2012

A calculator for prostate cancer risk 4 years after an initially negative screen: Findings from ERSPC Rotterdam - Abstract August 29, 2012

A rare case of metastatic ductal type prostate adenocarcinoma presenting with syndrome of inappropriate secretion of antidiuretic hormone: A case report and review - Abstract August 29, 2012

Salvage radiotherapy after radical prostatectomy: Outcomes and prognostic factors especially focusing on pathological findings - Abstract August 29, 2012

Computerized estimation of patient setup errors in portal images based on localized pelvic templates for prostate cancer radiotherapy - Abstract August 29, 2012

Surveillance on interfacility differences in dose-prescription policy of intensity-modulated radiation therapy plans for prostate cancer - Abstract August 29, 2012

Uncertainty in patient set-up margin analysis in radiation therapy - Abstract August 29, 2012

Prostate cancer aggressiveness: In vivo assessment of MR spectroscopy and diffusion-weighted imaging at 3 T - Abstract August 29, 2012

Biochemical failure after carbon ion radiotherapy for prostate cancer - Abstract August 29, 2012

Dexamethasone plus somatostatin-analog manipulation as bone metastasis microenvironment-targeting therapy for the treatment of castration-resistant prostate cancer: A meta-analysis of uncontrolled studies - Abstract August 29, 2012

No additional benefit of adding ifosfamide to docetaxel in castration-resistant metastatic prostate cancer - Abstract August 29, 2012

MRI and ultrasound-guided prostate biopsy using soft image fusion - Abstract August 29, 2012

Preliminary experience on the use of the Adnatest(R) system for detection of circulating tumor cells in prostate cancer patients - Abstract August 29, 2012

Applications of transrectal ultrasound in prostate cancer - Abstract August 29, 2012

U.S. FDA grants priority review of ZYTIGA® (abiraterone acetate) sNDA for treatment of metastatic castration-resistant prostate cancer before chemotherapy August 29, 2012

NPIP: A skew line needle configuration optimization system for HDR brachytherapy - Abstract August 28, 2012

Clinical outcomes of high-dose-rate brachytherapy and external beam radiotherapy in the management of clinically localized prostate cancer - Abstract August 28, 2012

Management and challenges of corticosteroid therapy in men with metastatic castrate-resistant prostate cancer - Abstract August 28, 2012

Sipuleucel-T (Provenge) autologous vaccine approved for treatment of men with asymptomatic or minimally symptomatic castrate-resistant metastatic prostate cancer - Abstract August 28, 2012

Patient satisfaction influenced by interpersonal treatment and communication for African American men: The North Carolina-Louisiana Prostate Cancer Project (PCaP) - Abstract August 28, 2012

Page 1247 of 1434